Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Neoplasms | 18 | 2022 | 794 | 2.880 |
Why?
|
Receptors, CXCR5 | 5 | 2019 | 15 | 2.150 |
Why?
|
Chemokine CXCL13 | 6 | 2019 | 18 | 1.890 |
Why?
|
Immunity, Mucosal | 11 | 2008 | 45 | 1.800 |
Why?
|
Cell Movement | 17 | 2019 | 545 | 1.710 |
Why?
|
T-Lymphocytes, Helper-Inducer | 8 | 2014 | 41 | 1.690 |
Why?
|
Chemokines, CC | 9 | 2014 | 50 | 1.680 |
Why?
|
Chemokine CCL5 | 7 | 2018 | 38 | 1.300 |
Why?
|
Streptococcus pneumoniae | 4 | 2014 | 28 | 1.270 |
Why?
|
Bacterial Proteins | 7 | 2014 | 520 | 1.270 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2022 | 18 | 1.230 |
Why?
|
Receptors, Chemokine | 10 | 2016 | 68 | 1.230 |
Why?
|
Neoplasm Invasiveness | 9 | 2016 | 247 | 1.210 |
Why?
|
Colitis | 5 | 2008 | 64 | 1.200 |
Why?
|
Receptors, CCR | 6 | 2014 | 24 | 1.160 |
Why?
|
Pneumococcal Infections | 4 | 2014 | 27 | 1.120 |
Why?
|
Epitopes, T-Lymphocyte | 5 | 2014 | 55 | 1.000 |
Why?
|
Chemokines, CXC | 6 | 2016 | 35 | 1.000 |
Why?
|
Cytokines | 12 | 2010 | 569 | 0.900 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2019 | 781 | 0.900 |
Why?
|
Cell Line, Tumor | 23 | 2019 | 2128 | 0.880 |
Why?
|
Entrepreneurship | 1 | 2021 | 5 | 0.850 |
Why?
|
Biotechnology | 1 | 2021 | 15 | 0.840 |
Why?
|
Adjuvants, Immunologic | 6 | 2004 | 106 | 0.830 |
Why?
|
CD4-Positive T-Lymphocytes | 11 | 2010 | 251 | 0.780 |
Why?
|
Metalloproteases | 3 | 2015 | 16 | 0.780 |
Why?
|
Interferon-gamma | 6 | 2014 | 235 | 0.770 |
Why?
|
Drug Delivery Systems | 4 | 2017 | 182 | 0.760 |
Why?
|
Chemokines | 5 | 2011 | 89 | 0.710 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2015 | 82 | 0.710 |
Why?
|
Mice | 26 | 2014 | 5668 | 0.700 |
Why?
|
Receptors, CXCR4 | 3 | 2013 | 67 | 0.690 |
Why?
|
Mycobacterium avium subsp. paratuberculosis | 2 | 2008 | 6 | 0.640 |
Why?
|
Mice, Inbred BALB C | 9 | 2014 | 649 | 0.620 |
Why?
|
Killer Cells, Natural | 2 | 2008 | 86 | 0.610 |
Why?
|
Prostate | 5 | 2016 | 136 | 0.600 |
Why?
|
Nasal Mucosa | 6 | 2004 | 29 | 0.600 |
Why?
|
Nanoparticles | 5 | 2020 | 294 | 0.600 |
Why?
|
Epitopes | 2 | 2011 | 145 | 0.600 |
Why?
|
Matrix Metalloproteinases | 4 | 2019 | 44 | 0.590 |
Why?
|
Epitope Mapping | 2 | 2014 | 31 | 0.590 |
Why?
|
Apoptosis | 15 | 2020 | 1317 | 0.590 |
Why?
|
Humans | 54 | 2022 | 34853 | 0.580 |
Why?
|
Receptors, CXCR3 | 7 | 2016 | 30 | 0.570 |
Why?
|
Animals | 32 | 2020 | 14307 | 0.560 |
Why?
|
Signal Transduction | 7 | 2020 | 1802 | 0.550 |
Why?
|
Ovalbumin | 7 | 2004 | 43 | 0.520 |
Why?
|
Ovarian Neoplasms | 3 | 2019 | 303 | 0.510 |
Why?
|
Immunodominant Epitopes | 1 | 2014 | 27 | 0.490 |
Why?
|
Th1 Cells | 6 | 2008 | 87 | 0.490 |
Why?
|
Interleukin-10 | 4 | 2010 | 69 | 0.490 |
Why?
|
Cell Proliferation | 13 | 2020 | 1149 | 0.490 |
Why?
|
Peptides | 3 | 2017 | 308 | 0.480 |
Why?
|
Female | 29 | 2021 | 19873 | 0.480 |
Why?
|
Antibodies, Bacterial | 3 | 2008 | 107 | 0.470 |
Why?
|
GTP-Binding Proteins | 1 | 2013 | 57 | 0.460 |
Why?
|
Protein Subunits | 1 | 2013 | 85 | 0.450 |
Why?
|
Male | 22 | 2022 | 18870 | 0.440 |
Why?
|
Cell Adhesion | 3 | 2016 | 209 | 0.440 |
Why?
|
Prostatic Hyperplasia | 2 | 2009 | 33 | 0.440 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2020 | 209 | 0.430 |
Why?
|
Immunoglobulin G | 8 | 2008 | 232 | 0.430 |
Why?
|
Breast Neoplasms | 5 | 2020 | 1426 | 0.420 |
Why?
|
Proteins | 3 | 2008 | 352 | 0.420 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 6 | 2010 | 445 | 0.410 |
Why?
|
RNA, Messenger | 8 | 2019 | 1152 | 0.410 |
Why?
|
Focal Adhesion Kinase 1 | 2 | 2011 | 18 | 0.400 |
Why?
|
Yersinia pestis | 4 | 1999 | 35 | 0.400 |
Why?
|
Hemin | 3 | 1999 | 5 | 0.380 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2010 | 28 | 0.370 |
Why?
|
Mice, Knockout | 7 | 2011 | 897 | 0.370 |
Why?
|
Chemokine CXCL10 | 2 | 2008 | 37 | 0.370 |
Why?
|
src-Family Kinases | 1 | 2010 | 42 | 0.370 |
Why?
|
T-Lymphocytes | 3 | 2008 | 341 | 0.370 |
Why?
|
Epithelial Cells | 5 | 2017 | 366 | 0.360 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2010 | 160 | 0.360 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2008 | 85 | 0.350 |
Why?
|
Mice, Inbred C57BL | 10 | 2011 | 1530 | 0.350 |
Why?
|
Integrins | 1 | 2009 | 49 | 0.350 |
Why?
|
Caspase 9 | 1 | 2009 | 27 | 0.350 |
Why?
|
Neutrophils | 4 | 2008 | 124 | 0.340 |
Why?
|
Antineoplastic Agents | 6 | 2019 | 756 | 0.340 |
Why?
|
Chlamydia Infections | 2 | 2008 | 196 | 0.340 |
Why?
|
HIV Envelope Protein gp120 | 1 | 2009 | 54 | 0.340 |
Why?
|
Immunoglobulin A | 6 | 2008 | 58 | 0.330 |
Why?
|
Membrane Transport Proteins | 2 | 2009 | 88 | 0.330 |
Why?
|
Technology, Pharmaceutical | 1 | 2008 | 25 | 0.330 |
Why?
|
Lymphocyte Activation | 5 | 2014 | 222 | 0.330 |
Why?
|
Receptors, CCR5 | 5 | 2018 | 59 | 0.330 |
Why?
|
Antibodies | 2 | 2008 | 135 | 0.330 |
Why?
|
Adenocarcinoma | 3 | 2014 | 239 | 0.320 |
Why?
|
Caspase 3 | 1 | 2009 | 194 | 0.320 |
Why?
|
Chlamydia muridarum | 1 | 2008 | 104 | 0.310 |
Why?
|
Paratuberculosis | 1 | 2007 | 3 | 0.310 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2017 | 605 | 0.300 |
Why?
|
Taxoids | 2 | 2017 | 36 | 0.300 |
Why?
|
Flow Cytometry | 6 | 2016 | 392 | 0.290 |
Why?
|
Tumor Cells, Cultured | 5 | 2016 | 480 | 0.290 |
Why?
|
Spleen | 4 | 2014 | 192 | 0.280 |
Why?
|
Membrane Proteins | 4 | 2019 | 486 | 0.280 |
Why?
|
Protein Binding | 4 | 2014 | 913 | 0.280 |
Why?
|
Carrier State | 1 | 2006 | 32 | 0.280 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 178 | 0.270 |
Why?
|
Receptors, Virus | 2 | 2016 | 20 | 0.270 |
Why?
|
T-Lymphocyte Subsets | 5 | 2007 | 84 | 0.260 |
Why?
|
Lipoproteins | 1 | 2005 | 61 | 0.260 |
Why?
|
Receptors, Interleukin-8B | 1 | 2004 | 20 | 0.250 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2017 | 200 | 0.250 |
Why?
|
Immunity, Cellular | 5 | 2008 | 68 | 0.250 |
Why?
|
Disease Progression | 3 | 2019 | 580 | 0.250 |
Why?
|
Enterocolitis | 1 | 2003 | 2 | 0.240 |
Why?
|
Adoptive Transfer | 1 | 2003 | 48 | 0.240 |
Why?
|
Adaptation, Physiological | 1 | 2004 | 106 | 0.240 |
Why?
|
Blotting, Western | 5 | 2017 | 834 | 0.230 |
Why?
|
Macrophage Inflammatory Proteins | 1 | 2002 | 14 | 0.220 |
Why?
|
Amino Acid Sequence | 5 | 2014 | 1124 | 0.220 |
Why?
|
Immunoenzyme Techniques | 3 | 2016 | 105 | 0.220 |
Why?
|
Chemokines, C | 2 | 1999 | 2 | 0.220 |
Why?
|
Molecular Sequence Data | 5 | 2014 | 1490 | 0.220 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2014 | 29 | 0.220 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2021 | 10 | 0.210 |
Why?
|
Disease Models, Animal | 4 | 2008 | 1300 | 0.210 |
Why?
|
Physician-Patient Relations | 1 | 2022 | 118 | 0.210 |
Why?
|
Salmonella typhimurium | 1 | 2001 | 40 | 0.210 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2008 | 325 | 0.200 |
Why?
|
Antibody Formation | 3 | 2008 | 73 | 0.200 |
Why?
|
Administration, Intranasal | 5 | 2002 | 77 | 0.200 |
Why?
|
Cluster Analysis | 2 | 2019 | 188 | 0.200 |
Why?
|
Ligands | 3 | 2007 | 317 | 0.190 |
Why?
|
Lung Neoplasms | 2 | 2015 | 336 | 0.190 |
Why?
|
Neoplasm Metastasis | 4 | 2019 | 211 | 0.190 |
Why?
|
Sialoglycoproteins | 2 | 1999 | 10 | 0.190 |
Why?
|
Lymphokines | 2 | 1999 | 11 | 0.190 |
Why?
|
Hedgehog Proteins | 1 | 2020 | 45 | 0.190 |
Why?
|
Systems Theory | 1 | 2019 | 3 | 0.180 |
Why?
|
Principal Component Analysis | 1 | 2019 | 79 | 0.180 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 198 | 0.180 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2007 | 57 | 0.180 |
Why?
|
Receptors, Scavenger | 2 | 2016 | 13 | 0.170 |
Why?
|
Gene Expression Profiling | 3 | 2019 | 600 | 0.170 |
Why?
|
Plague | 1 | 1999 | 24 | 0.170 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 115 | 0.170 |
Why?
|
Immunity | 1 | 1999 | 51 | 0.170 |
Why?
|
Biological Products | 1 | 2020 | 67 | 0.170 |
Why?
|
Mutation | 6 | 2022 | 1023 | 0.170 |
Why?
|
Cell Division | 3 | 2005 | 296 | 0.170 |
Why?
|
GTPase-Activating Proteins | 2 | 2010 | 26 | 0.160 |
Why?
|
Drug Resistance, Multiple | 1 | 2018 | 26 | 0.160 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 2 | 2017 | 51 | 0.160 |
Why?
|
Liposomes | 2 | 2009 | 107 | 0.160 |
Why?
|
Embryonic Stem Cells | 2 | 2008 | 57 | 0.160 |
Why?
|
Healthcare Disparities | 1 | 2022 | 446 | 0.160 |
Why?
|
Image Cytometry | 2 | 2007 | 6 | 0.160 |
Why?
|
Dendritic Cells | 2 | 2008 | 112 | 0.150 |
Why?
|
Cytoskeleton | 2 | 2016 | 98 | 0.150 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2017 | 21 | 0.150 |
Why?
|
Clusterin | 1 | 2017 | 9 | 0.150 |
Why?
|
Prognosis | 3 | 2022 | 707 | 0.150 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2017 | 54 | 0.150 |
Why?
|
Epithelium | 1 | 2017 | 74 | 0.150 |
Why?
|
Interleukin-6 | 3 | 2009 | 140 | 0.150 |
Why?
|
Stilbenes | 1 | 2017 | 41 | 0.150 |
Why?
|
Receptors, CCR6 | 1 | 2016 | 3 | 0.140 |
Why?
|
Curcumin | 1 | 2017 | 66 | 0.140 |
Why?
|
Serum Amyloid A Protein | 2 | 2008 | 14 | 0.140 |
Why?
|
Pancreatic Neoplasms | 1 | 2018 | 106 | 0.140 |
Why?
|
Andrographis | 1 | 2016 | 4 | 0.140 |
Why?
|
Receptors, CXCR | 1 | 2016 | 6 | 0.140 |
Why?
|
Integrin alphaVbeta3 | 1 | 2016 | 12 | 0.140 |
Why?
|
Receptors, Androgen | 1 | 2017 | 122 | 0.140 |
Why?
|
Mice, Inbred Strains | 2 | 2010 | 117 | 0.140 |
Why?
|
Treatment Outcome | 1 | 2019 | 1349 | 0.130 |
Why?
|
Nerve Tissue Proteins | 2 | 2015 | 338 | 0.130 |
Why?
|
Exosomes | 1 | 2017 | 97 | 0.130 |
Why?
|
Diterpenes | 1 | 2016 | 83 | 0.130 |
Why?
|
Antigens, Bacterial | 2 | 2007 | 129 | 0.130 |
Why?
|
Nanostructures | 1 | 2017 | 133 | 0.130 |
Why?
|
Cytoskeletal Proteins | 1 | 2016 | 97 | 0.130 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2008 | 150 | 0.130 |
Why?
|
Neoplasm Staging | 2 | 2019 | 269 | 0.130 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2016 | 107 | 0.120 |
Why?
|
HLA Antigens | 1 | 2014 | 19 | 0.120 |
Why?
|
Interleukins | 1 | 2014 | 28 | 0.120 |
Why?
|
Antibody Specificity | 2 | 2004 | 75 | 0.120 |
Why?
|
Gene Expression Regulation | 3 | 2008 | 968 | 0.120 |
Why?
|
Colonic Neoplasms | 1 | 2016 | 181 | 0.120 |
Why?
|
Coculture Techniques | 1 | 2014 | 96 | 0.120 |
Why?
|
Gene Deletion | 2 | 2005 | 156 | 0.120 |
Why?
|
Lymph Nodes | 1 | 2014 | 67 | 0.120 |
Why?
|
Tissue Array Analysis | 2 | 2011 | 65 | 0.120 |
Why?
|
Chemokine CXCL11 | 2 | 2016 | 7 | 0.120 |
Why?
|
Protein Structure, Secondary | 1 | 2014 | 172 | 0.120 |
Why?
|
Receptor, PAR-1 | 1 | 2013 | 9 | 0.120 |
Why?
|
Thrombin | 1 | 2013 | 24 | 0.120 |
Why?
|
Intestinal Mucosa | 2 | 2007 | 115 | 0.120 |
Why?
|
Up-Regulation | 3 | 2005 | 490 | 0.120 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2013 | 30 | 0.120 |
Why?
|
Antigens, CD | 2 | 2004 | 116 | 0.110 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2013 | 44 | 0.110 |
Why?
|
Immunohistochemistry | 2 | 2016 | 859 | 0.110 |
Why?
|
Cells, Cultured | 3 | 2006 | 1442 | 0.110 |
Why?
|
Protein Isoforms | 1 | 2013 | 121 | 0.110 |
Why?
|
Nanotechnology | 2 | 2017 | 150 | 0.110 |
Why?
|
United States | 1 | 2022 | 3894 | 0.110 |
Why?
|
Cell Survival | 4 | 2018 | 818 | 0.110 |
Why?
|
Th2 Cells | 3 | 2001 | 56 | 0.110 |
Why?
|
Proteomics | 3 | 2022 | 302 | 0.100 |
Why?
|
Mice, SCID | 2 | 2009 | 143 | 0.100 |
Why?
|
Smoke | 1 | 2011 | 39 | 0.100 |
Why?
|
B-Lymphocytes | 2 | 2004 | 181 | 0.100 |
Why?
|
Cell Separation | 2 | 2008 | 91 | 0.100 |
Why?
|
Mice, Transgenic | 2 | 2004 | 608 | 0.100 |
Why?
|
Cisplatin | 1 | 2011 | 70 | 0.100 |
Why?
|
Chemokine CXCL5 | 1 | 2010 | 5 | 0.100 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2011 | 89 | 0.100 |
Why?
|
Models, Molecular | 1 | 2014 | 751 | 0.100 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2010 | 8 | 0.090 |
Why?
|
Histocompatibility Antigens | 1 | 2010 | 12 | 0.090 |
Why?
|
Neoplasms | 2 | 2011 | 1033 | 0.090 |
Why?
|
Binding, Competitive | 1 | 2010 | 103 | 0.090 |
Why?
|
Reproducibility of Results | 1 | 2013 | 901 | 0.090 |
Why?
|
Interleukin-12 | 2 | 2001 | 46 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2016 | 984 | 0.090 |
Why?
|
Models, Biological | 1 | 2013 | 642 | 0.090 |
Why?
|
Prostatic Intraepithelial Neoplasia | 1 | 2009 | 13 | 0.090 |
Why?
|
Stromal Cells | 1 | 2009 | 45 | 0.090 |
Why?
|
Dendrimers | 1 | 2009 | 13 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2010 | 157 | 0.090 |
Why?
|
Antigens, CD34 | 1 | 2009 | 18 | 0.090 |
Why?
|
Enzyme Activation | 1 | 2010 | 423 | 0.090 |
Why?
|
Micelles | 1 | 2009 | 31 | 0.090 |
Why?
|
Quantum Dots | 1 | 2009 | 26 | 0.080 |
Why?
|
DNA Damage | 1 | 2011 | 341 | 0.080 |
Why?
|
Absorption | 1 | 2008 | 22 | 0.080 |
Why?
|
Hydrogels | 1 | 2009 | 33 | 0.080 |
Why?
|
Bone and Bones | 1 | 2009 | 89 | 0.080 |
Why?
|
Prostate-Specific Antigen | 1 | 2009 | 95 | 0.080 |
Why?
|
Glycoproteins | 1 | 2009 | 100 | 0.080 |
Why?
|
Interleukin-12 Subunit p40 | 1 | 2008 | 5 | 0.080 |
Why?
|
Drug Stability | 1 | 2008 | 110 | 0.080 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2011 | 248 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2009 | 242 | 0.080 |
Why?
|
Bacterial Outer Membrane Proteins | 2 | 1999 | 50 | 0.080 |
Why?
|
Biocompatible Materials | 1 | 2008 | 75 | 0.080 |
Why?
|
Administration, Oral | 1 | 2008 | 212 | 0.080 |
Why?
|
Drug Synergism | 2 | 2019 | 171 | 0.080 |
Why?
|
Particle Size | 1 | 2008 | 200 | 0.080 |
Why?
|
Hematopoietic Stem Cells | 1 | 2007 | 43 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2008 | 57 | 0.080 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2007 | 19 | 0.080 |
Why?
|
Amyloid Precursor Protein Secretases | 2 | 2019 | 33 | 0.080 |
Why?
|
Cytoplasm | 1 | 2007 | 135 | 0.080 |
Why?
|
Polymers | 1 | 2008 | 117 | 0.080 |
Why?
|
Drug Carriers | 1 | 2008 | 121 | 0.080 |
Why?
|
Immunoglobulin A, Secretory | 2 | 2004 | 16 | 0.080 |
Why?
|
Inflammation Mediators | 1 | 2008 | 120 | 0.070 |
Why?
|
Intracellular Membranes | 1 | 2006 | 34 | 0.070 |
Why?
|
ADP-Ribosylation Factors | 1 | 2006 | 12 | 0.070 |
Why?
|
Membrane Glycoproteins | 2 | 2005 | 197 | 0.070 |
Why?
|
Plasmodium yoelii | 1 | 2005 | 10 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2010 | 638 | 0.070 |
Why?
|
Dermatitis | 1 | 2005 | 8 | 0.070 |
Why?
|
Cell Nucleus | 1 | 2007 | 351 | 0.070 |
Why?
|
Cerebellum | 1 | 2005 | 69 | 0.070 |
Why?
|
Oxidative Stress | 1 | 2011 | 874 | 0.070 |
Why?
|
Infertility, Female | 1 | 2005 | 24 | 0.070 |
Why?
|
Genital Diseases, Female | 1 | 2005 | 37 | 0.070 |
Why?
|
Plant Extracts | 2 | 2020 | 250 | 0.070 |
Why?
|
Malaria | 1 | 2005 | 68 | 0.070 |
Why?
|
Gene Products, nef | 1 | 2005 | 19 | 0.070 |
Why?
|
Chemokine CCL1 | 1 | 2004 | 2 | 0.070 |
Why?
|
Adhesins, Bacterial | 1 | 2005 | 18 | 0.070 |
Why?
|
Chlamydia trachomatis | 1 | 2005 | 66 | 0.070 |
Why?
|
Chemokine CXCL6 | 1 | 2004 | 2 | 0.060 |
Why?
|
Antigens, Surface | 1 | 2004 | 39 | 0.060 |
Why?
|
Chemokine CXCL12 | 1 | 2004 | 28 | 0.060 |
Why?
|
Peptide Hormones | 1 | 2004 | 19 | 0.060 |
Why?
|
Skin | 1 | 2005 | 173 | 0.060 |
Why?
|
Leukocytes | 1 | 2004 | 68 | 0.060 |
Why?
|
Cell Cycle Proteins | 2 | 2017 | 220 | 0.060 |
Why?
|
Species Specificity | 1 | 2004 | 233 | 0.060 |
Why?
|
Reaction Time | 1 | 2004 | 130 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2004 | 550 | 0.060 |
Why?
|
Malaria, Cerebral | 1 | 2004 | 31 | 0.060 |
Why?
|
Immunity, Innate | 1 | 2004 | 135 | 0.060 |
Why?
|
Inflammation | 2 | 2005 | 577 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2004 | 69 | 0.060 |
Why?
|
Immunization, Passive | 1 | 2003 | 18 | 0.060 |
Why?
|
Immune Sera | 1 | 2003 | 59 | 0.060 |
Why?
|
Injections, Intraperitoneal | 1 | 2003 | 58 | 0.060 |
Why?
|
Apolipoproteins | 1 | 2003 | 19 | 0.060 |
Why?
|
Rabbits | 1 | 2003 | 278 | 0.060 |
Why?
|
Crohn Disease | 1 | 2003 | 55 | 0.060 |
Why?
|
Leptin | 1 | 2004 | 115 | 0.060 |
Why?
|
Chemokine CCL3 | 1 | 2002 | 13 | 0.060 |
Why?
|
Chemokine CCL4 | 1 | 2002 | 18 | 0.060 |
Why?
|
Immunoglobulin Isotypes | 1 | 2002 | 16 | 0.060 |
Why?
|
Feces | 1 | 2003 | 110 | 0.060 |
Why?
|
Hela Cells | 2 | 2006 | 344 | 0.060 |
Why?
|
Weight Loss | 1 | 2003 | 124 | 0.050 |
Why?
|
Defensins | 2 | 1999 | 5 | 0.050 |
Why?
|
Monocytes | 1 | 2004 | 258 | 0.050 |
Why?
|
Peyer's Patches | 1 | 2001 | 15 | 0.050 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2021 | 62 | 0.050 |
Why?
|
Restriction Mapping | 2 | 1999 | 42 | 0.050 |
Why?
|
Receptors, Interleukin-12 | 1 | 2001 | 1 | 0.050 |
Why?
|
Antibody-Producing Cells | 1 | 2001 | 5 | 0.050 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 56 | 0.050 |
Why?
|
Interphase | 1 | 2001 | 6 | 0.050 |
Why?
|
Base Sequence | 3 | 1999 | 932 | 0.050 |
Why?
|
Receptors, Interleukin | 1 | 2001 | 10 | 0.050 |
Why?
|
B-Lymphocyte Subsets | 1 | 2001 | 16 | 0.050 |
Why?
|
Temperature | 2 | 1999 | 275 | 0.050 |
Why?
|
Aged | 3 | 2021 | 6448 | 0.050 |
Why?
|
Immunoglobulin M | 1 | 2001 | 81 | 0.050 |
Why?
|
Nuclear Proteins | 2 | 2016 | 287 | 0.050 |
Why?
|
Adult | 3 | 2015 | 11034 | 0.050 |
Why?
|
Receptors, Cell Surface | 2 | 2005 | 135 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2005 | 413 | 0.040 |
Why?
|
Phenotype | 2 | 1999 | 650 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2014 | 1056 | 0.040 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 1999 | 23 | 0.040 |
Why?
|
Genes, Bacterial | 1 | 1999 | 88 | 0.040 |
Why?
|
Sequence Analysis, DNA | 2 | 1999 | 455 | 0.040 |
Why?
|
Lethal Dose 50 | 1 | 1999 | 30 | 0.040 |
Why?
|
alpha-Defensins | 1 | 1999 | 15 | 0.040 |
Why?
|
Iron Chelating Agents | 1 | 1999 | 21 | 0.040 |
Why?
|
Superoxides | 1 | 1999 | 51 | 0.040 |
Why?
|
Bacterial Adhesion | 1 | 1999 | 36 | 0.040 |
Why?
|
Chlorides | 1 | 1999 | 52 | 0.040 |
Why?
|
Immunization | 1 | 1999 | 90 | 0.040 |
Why?
|
Ferric Compounds | 1 | 1999 | 49 | 0.040 |
Why?
|
Octamer Transcription Factor-3 | 2 | 2008 | 18 | 0.040 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 1999 | 145 | 0.040 |
Why?
|
Ovary | 1 | 2019 | 101 | 0.040 |
Why?
|
Middle Aged | 3 | 2021 | 9642 | 0.040 |
Why?
|
Virulence | 1 | 1999 | 221 | 0.040 |
Why?
|
Folic Acid | 1 | 2018 | 46 | 0.040 |
Why?
|
Hydrogen Peroxide | 1 | 1999 | 181 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 1997 | 15 | 0.040 |
Why?
|
Microscopy, Confocal | 2 | 2008 | 210 | 0.040 |
Why?
|
Pigmentation | 1 | 1997 | 9 | 0.040 |
Why?
|
Lipopolysaccharides | 1 | 1999 | 200 | 0.040 |
Why?
|
Operon | 1 | 1997 | 43 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2019 | 282 | 0.040 |
Why?
|
Kinetics | 1 | 1999 | 650 | 0.040 |
Why?
|
Caco-2 Cells | 1 | 2017 | 48 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2015 | 2333 | 0.040 |
Why?
|
Immunoblotting | 1 | 2017 | 170 | 0.040 |
Why?
|
Surface Properties | 1 | 2017 | 121 | 0.040 |
Why?
|
Polyethylene Glycols | 1 | 2017 | 80 | 0.040 |
Why?
|
Nitric Oxide | 1 | 1999 | 287 | 0.040 |
Why?
|
Chemokine CCL20 | 1 | 2016 | 7 | 0.040 |
Why?
|
Reactive Oxygen Species | 1 | 1999 | 416 | 0.040 |
Why?
|
NF-kappa B | 1 | 2019 | 306 | 0.040 |
Why?
|
Androgens | 1 | 2017 | 87 | 0.040 |
Why?
|
Microscopy, Fluorescence | 1 | 2017 | 240 | 0.040 |
Why?
|
Cyclin B1 | 1 | 2016 | 16 | 0.040 |
Why?
|
CDC2 Protein Kinase | 1 | 2016 | 17 | 0.040 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2016 | 24 | 0.040 |
Why?
|
Cyclins | 1 | 2016 | 35 | 0.030 |
Why?
|
Retinoblastoma Protein | 1 | 2016 | 27 | 0.030 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2017 | 146 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2016 | 29 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2017 | 165 | 0.030 |
Why?
|
Escherichia coli | 1 | 1999 | 436 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2015 | 41 | 0.030 |
Why?
|
Siderophores | 1 | 1995 | 9 | 0.030 |
Why?
|
ADAM Proteins | 1 | 2015 | 15 | 0.030 |
Why?
|
Receptors, CCR3 | 2 | 2005 | 10 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 1997 | 484 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2016 | 121 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 164 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2005 | 298 | 0.030 |
Why?
|
Histones | 1 | 2016 | 177 | 0.030 |
Why?
|
Cell Line | 1 | 2018 | 1289 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 528 | 0.030 |
Why?
|
Phosphorylation | 1 | 2016 | 878 | 0.030 |
Why?
|
Risk Factors | 2 | 2011 | 3414 | 0.030 |
Why?
|
Cell Transformation, Viral | 1 | 2011 | 29 | 0.030 |
Why?
|
Receptor Cross-Talk | 1 | 2011 | 16 | 0.030 |
Why?
|
Models, Immunological | 1 | 2011 | 20 | 0.030 |
Why?
|
Genes, p53 | 1 | 2011 | 24 | 0.030 |
Why?
|
Deoxyguanosine | 1 | 2011 | 34 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 2011 | 87 | 0.030 |
Why?
|
Human papillomavirus 16 | 1 | 2011 | 34 | 0.030 |
Why?
|
Health Status Disparities | 1 | 2017 | 583 | 0.020 |
Why?
|
Receptors, Interleukin-10 | 1 | 2010 | 3 | 0.020 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2010 | 24 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2010 | 58 | 0.020 |
Why?
|
DNA Repair | 1 | 2011 | 181 | 0.020 |
Why?
|
Cell Cycle | 1 | 2011 | 309 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2011 | 245 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2010 | 91 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2008 | 75 | 0.020 |
Why?
|
Bone Marrow | 1 | 2007 | 34 | 0.020 |
Why?
|
Cell Size | 1 | 2007 | 42 | 0.020 |
Why?
|
Granulocytes | 1 | 2007 | 28 | 0.020 |
Why?
|
Papillomavirus Infections | 1 | 2011 | 316 | 0.020 |
Why?
|
Logistic Models | 1 | 2010 | 894 | 0.020 |
Why?
|
Aluminum Compounds | 1 | 2006 | 8 | 0.020 |
Why?
|
Phosphatidylinositol 4,5-Diphosphate | 1 | 2006 | 6 | 0.020 |
Why?
|
Fluorides | 1 | 2006 | 19 | 0.020 |
Why?
|
Epidermal Growth Factor | 1 | 2006 | 63 | 0.020 |
Why?
|
Membrane Microdomains | 1 | 2006 | 46 | 0.020 |
Why?
|
Receptors, CCR1 | 1 | 2005 | 8 | 0.020 |
Why?
|
Chemokine CCL11 | 1 | 2005 | 1 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2006 | 122 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2007 | 173 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2005 | 78 | 0.020 |
Why?
|
Protein Transport | 1 | 2007 | 286 | 0.020 |
Why?
|
Young Adult | 1 | 2015 | 4012 | 0.020 |
Why?
|
Fallopian Tubes | 1 | 2005 | 16 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2005 | 44 | 0.020 |
Why?
|
Actins | 1 | 2006 | 142 | 0.020 |
Why?
|
Toll-Like Receptors | 1 | 2005 | 47 | 0.020 |
Why?
|
DNA Primers | 1 | 2005 | 269 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2005 | 36 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2005 | 87 | 0.020 |
Why?
|
Receptors, Ghrelin | 1 | 2004 | 1 | 0.020 |
Why?
|
Receptors, Leptin | 1 | 2004 | 13 | 0.020 |
Why?
|
Ghrelin | 1 | 2004 | 12 | 0.020 |
Why?
|
Human Growth Hormone | 1 | 2004 | 20 | 0.020 |
Why?
|
Fibroblasts | 1 | 2005 | 252 | 0.020 |
Why?
|
Cell Membrane | 1 | 2006 | 360 | 0.020 |
Why?
|
Gene Expression | 1 | 2005 | 639 | 0.010 |
Why?
|
Chronic Disease | 1 | 2005 | 469 | 0.010 |
Why?
|
Time Factors | 1 | 2005 | 1681 | 0.010 |
Why?
|
Child, Preschool | 1 | 2004 | 1318 | 0.010 |
Why?
|
Tetanus Toxoid | 1 | 1999 | 2 | 0.010 |
Why?
|
HIV-1 | 1 | 2005 | 678 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 1999 | 90 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1999 | 257 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1999 | 123 | 0.010 |
Why?
|
Plasmids | 1 | 1999 | 233 | 0.010 |
Why?
|
Vaccines | 1 | 1999 | 49 | 0.010 |
Why?
|
Brain | 1 | 2004 | 1268 | 0.010 |
Why?
|
Child | 1 | 2004 | 2875 | 0.010 |
Why?
|
Bacteriocins | 1 | 1995 | 6 | 0.010 |
Why?
|